Foreign Demand for Coal Continues to Grow

RDInvesting Provides Stock Research on CONSOL Energy and Natural Resource Partners

Continue Reading

Foreign Demand for Coal Remains Strong — China Coal Consumption Nearly Equal to Rest of the World Combined

RDInvesting Provides Stock Research on Arch Coal and James River Coal

Continue Reading

FDA Approved a Total of 39 New Drugs in 2012 — Fifteen Year High

Research Driven Investing Provides Stocks Research on Halozyme Therapeutics and NuPathe

Continue Reading

Number of FDA Drug Approvals Reach a 15-Year High in 2012

Research Driven Investing Provides Stocks Research on Nektar Therapeutics and Threshold

Continue Reading

China-s Hunger for Coals Expected to Drive Coal Industry in 2013

RDInvesting Provides Stock Research on Cloud Peak Energy and Walter Energy

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012

Research Driven Investing Provides Stocks Research on Amgen and Gilead Sciences

Continue Reading

Coal Industry Expected to Rebound on Growing Demand From China in 2013

RDInvesting Provides Stock Research on Alpha Natural Resources and Peabody Energy

Continue Reading

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success

Research Driven Investing Provides Stocks Research on Geron and MannKind

Continue Reading

S&P 500 Companies Projected to Report a 3.8% Growth in Earnings — S&P 500 Index Hits 5-Year High

Research Driven Investing Provides Stocks Research on The Clorox Company and Leggett & Platt

Continue Reading

Strong Performance From Downstream Operations Help Drive Earnings for Chevron and Exxon Mobil

Research Driven Investing Provides Stocks Research on Chevron and Exxon Mobil Corporation

Continue Reading